Long-term outcome of treatment with protocols AL841, AL851, and ALHR88 in children with acute lymphoblastic leukemia: results obtained by the Kyushu-Yamaguchi Children's Cancer Study Group (Q34246747)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Long-term outcome of treatment with protocols AL841, AL851, and ALHR88 in children with acute lymphoblastic leukemia: results obtained by the Kyushu-Yamaguchi Children's Cancer Study Group	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1 reference

Europe PubMed Central

Long-term outcome of treatment with protocols AL841, AL851, and ALHR88 in children with acute lymphoblastic leukemia: results obtained by the Kyushu-Yamaguchi Children's Cancer Study Group (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

lymphoblastic leukemia

1 reference

based on heuristic

inferred from title

author name string

Matsuzaki A

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Ishii E

2

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Nagatoshi Y

3

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Eguchi H

4

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Koga H

5

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Yanai F

6

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Inada H

7

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Nibu K

8

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Tamai Y

9

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Akiyoshi K

10

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Nakayama H

11

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Hara T

12

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Take H

13

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Miyazaki S

14

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Okamura J

15

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

publication date

1 April 2001

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

International Journal of Hematology

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

73

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

369-377

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Long-term effects of treatment for acute lymphoblastic leukemia with and without cranial irradiation on growth and puberty: a comparative study

1 reference

https://api.crossref.org/works/10.1007%2FBF02981964

21 January 2018

Second neoplasms after acute lymphoblastic leukemia in childhood.

1 reference

https://api.crossref.org/works/10.1007%2FBF02981964

21 January 2018

Incidence of second primary tumours among childhood cancer survivors

1 reference

https://api.crossref.org/works/10.1007%2FBF02981964

21 January 2018

Conventional compared with individualized chemotherapy for childhood acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/11345205

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Secondary brain tumors in children treated for acute lymphoblastic leukemia at St Jude Children's Research Hospital

1 reference

https://pubmed.ncbi.nlm.nih.gov/11345205

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Growth in children treated for acute lymphoblastic leukaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/11345205

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of CNS disease in intermediate-risk acute lymphoblastic leukemia: comparison of cranial radiation and intrathecal methotrexate and the importance of systemic therapy: a Childrens Cancer Group report.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11345205

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ploidy of lymphoblasts is the strongest predictor of treatment outcome in B-progenitor cell acute lymphoblastic leukemia of childhood: a Pediatric Oncology Group study

1 reference

https://pubmed.ncbi.nlm.nih.gov/11345205

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11345205

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Six-year experience with a comprehensive approach to the treatment of recurrent childhood acute lymphoblastic leukemia (ALL-REZ BFM 85). A relapse study of the BFM group

1 reference

https://pubmed.ncbi.nlm.nih.gov/11345205

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Philadelphia chromosome in relapsed childhood acute lymphoblastic leukemia: a matched-pair analysis. Berlin-Frankfurt-Münster Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/11345205

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/11345205

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy plays a major role in the inhibition of catch-up growth during maintenance therapy for childhood acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/11345205

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Final height after treatment for childhood acute lymphoblastic leukemia: comparison of no cranial irradiation with 1800 and 2400 centigrays of cranial irradiation

1 reference

https://pubmed.ncbi.nlm.nih.gov/11345205

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster-based intensive chemotherapy. The Associazione Ital

1 reference

https://pubmed.ncbi.nlm.nih.gov/11345205

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patterns of obesity in boys and girls after treatment for acute lymphoblastic leukaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/11345205

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic bone marrow transplantation in second remission of childhood acute lymphoblastic leukemia: a population-based case control study from the Nordic countries

1 reference

https://pubmed.ncbi.nlm.nih.gov/11345205

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impaired pubertal growth in acute lymphoblastic leukaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/11345205

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic bone marrow transplantation vs chemotherapy for the treatment of childhood acute lymphoblastic leukaemia in second complete remission (revisited 10 years on)

1 reference

https://pubmed.ncbi.nlm.nih.gov/11345205

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Overview of clinical studies of childhood acute lymphoblastic leukemia for more than ten years by the Japanese Children's Cancer and Leukemia Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/11345205

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparable effects of 1800- and 2400-rad (18- and 24-Gy) cranial irradiation on height and weight in children treated for acute lymphocytic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/11345205

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of relapsing acute lymphoblastic leukemia in childhood. III. Experiences with 54 first bone marrow, nine isolated testicular, and eight isolated central nervous system relapses observed 1985-1989.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11345205

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High incidence of obesity in young adults after treatment of acute lymphoblastic leukemia in childhood

1 reference

https://pubmed.ncbi.nlm.nih.gov/11345205

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of standard-risk acute lymphoblastic leukemia in children: the results of protocol AL841 from the Kyushu-Yamaguchi Children's Cancer Study Group in Japan

1 reference

https://pubmed.ncbi.nlm.nih.gov/11345205

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Height of children successfully treated for acute lymphoblastic leukemia: a report from the Late Effects Study Committee of Childrens Cancer Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/11345205

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Growth and growth hormone secretion after treatment for acute lymphoblastic leukemia in childhood. 18-Gy versus 24-Gy cranial irradiation

1 reference

https://pubmed.ncbi.nlm.nih.gov/11345205

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X. Medical Research Council Working Party on Childhood Leukaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/11345205

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term endocrine sequelae after treatment of medulloblastoma: prospective study of growth and thyroid function

1 reference

https://pubmed.ncbi.nlm.nih.gov/11345205

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of acute lymphoblastic leukemia French protocol Fralle 83-87

1 reference

https://pubmed.ncbi.nlm.nih.gov/11345205

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of high-risk acute lymphoblastic leukemia in children using the AL851 and ALHR88 protocols: a report from the Kyushu-Yamaguchi Children's Cancer Study Group in Japan.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11345205

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adriamycin given as a weekly schedule without a loading course: clinically effective with reduced incidence of cardiotoxicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/11345205

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reinduction therapy in 297 children with acute lymphoblastic leukemia in first bone marrow relapse: a Pediatric Oncology Group Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/11345205

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Obesity after successful treatment of acute lymphoblastic leukemia in childhood

1 reference

https://pubmed.ncbi.nlm.nih.gov/11345205

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF02981964

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34246747&oldid=2196417298"